Covaxin Neutralises Double Mutant Strain In India: Research Body ICMR

Wednesday, 21 April 2021Newsdesk

Made-in-India COVID-19 vaccine, Covaxin, neutralises multiple variants of SARS-CoV-2 and effectively works against the double mutant strain as well, the Indian Council of Medical Research (ICMR) said today.

New Delhi, 21 April 2021

As per news report of NDTV, Bharat Biotech's Covaxin has received Emergency Use Authorizations (EUAs) for COVID-19 treatment in India and in several countries across the world with another 60 in the process. "ICMR study shows Covaxin neutralises against multiple variants of SARS-CoV-2 and effectively neutralises the double mutant strain as well," the ICMR tweeted.

Source -NDTV